Skip to search formSkip to main contentSkip to account menu

LY334370

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Discovery of selective N-[3-(1-methyl-piperidine-4-carbonyl)-phenyl]-benzamide-based 5-HT₁ F receptor agonists: Evolution from bicyclic to monocyclic cores.
2004
2004
Upcoming drugs for migraine
Migraine is a common, chronic incapacitating neurovascular disorder, characterized by attacks of severe headache, nausea… 
2004
2004
5‐HTIF Receptor Agonist
Selective Seratonin 1F (5-HT(1F)) Receptor Agonist LY334370 for Acute Migraine: A Randomised Controlled Trial BACKGROUND… 
2003
2003
Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides.
Compound 1a (LY334370), a selective 5-HT(1F) receptor agonist (SSOFRA), inhibited dural inflammation in the neurogenic plasma… 
2002
2002
Molecular cloning and expression of the porcine trigeminal ganglion cDNA encoding a 5-ht(1F) receptor.
Using a combination of reverse transcription polymerase chain reaction (RT-PCR) and inverse-PCR techniques, we amplified, cloned… 
1999
1999
Safety and pharmacokinetics of high doses of LY334370, a selective serotonin 1F receptor agonist (SSOFRA), during and outside an acute migraine attack.
1999
1999
Safety, pharmacokinetics and preliminary efficacy data of LY334370, a novel SSOFRA, in patients with acute migraine.
1999
1999
Pharmacokinetics and Safety of LY334370, A Novel Oral 5‐HT1F Selective Agonist, in Patients During Migraine
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)